Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children (Q35832867)

10 August 2017

title

Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children (English)

1 reference

10 August 2017

0 references

Danielle Barnes

1

1 reference

10 August 2017

Ann Ming Yeh

series ordinal

2

1 reference

10 August 2017

publication date

1 December 2015

1 reference

Nutrition in Clinical Practice

10 August 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 August 2017

volume

30

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

747-759

1 reference

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

The butyrate story: old wine in new bottles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

The human microbiome and its potential importance to pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Yogurt, living cultures, and gut health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Probiotics for the prevention of pediatric antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Probiotics for treating acute infectious diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Invasive Saccharomyces infection: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Possible role of catheters in Saccharomyces boulardii fungemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Identification and characterization of antibiotic resistance genes in Lactobacillus reuteri and Lactobacillus plantarum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Probiotics as prevention and treatment for diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children--updated analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Efficacy and safety of Saccharomyces boulardii for acute diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Meta-analysis shows limited evidence for using Lactobacillus acidophilus LB to treat acute gastroenteritis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

The role of Bifidobacterium lactis B94 plus inulin in the treatment of acute infectious diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Study to investigate the potential of probiotics in children attending school.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Modulation of Lactobacillus casei in ileal and fecal samples from healthy volunteers after consumption of a fermented milk containing Lactobacillus casei DN-114 001Rif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Burden of Clostridium difficile infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Clinical Characteristics of Symptomatic Clostridium difficile Infection in Children: Conditions as Infection Risks and Whether Probiotics Is Effective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Pathway to Prevention of Nosocomial Clostridium difficile Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

A pilot trial of Saccharomyces boulardii in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Effects of probiotic on intestinal mucosa of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Pouchitis--a poorly understood entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

High-dose probiotics for the treatment of active pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Lactobacillus GG in inducing and maintaining remission of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

The functional gastrointestinal disorders and the Rome III process

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Visceral pain and gastrointestinal microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Probiotics for childhood functional gastrointestinal disorders: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Fermented milk containing Bifidobacterium lactis DN-173 010 in childhood constipation: a randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615610081

21 January 2018

Identifiers

DOI

10.1177/0884533615610081

1 reference

10 August 2017

1 reference